|
|
Thomson Financial Business Description:
| The Group's principal activities are to discover, develop and commercialize differentiated products that address large and growing markets, unmet medical needs and are prescribed principally by primary care physicians and certain specialists. The products of the Group are XOPENEX(R) for the treatment or prevention of bronchospasm in patients six years of age and older with reversible obstructive airway disease. The XOPENEX HFA(R) for the treatment or prevention of bronchospasm in adults, adolescents and children four years of age and older with reversible obstructive airway disease. The BROVANA(R) which maintains a treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, or COPD including chronic and bronchitis. LUNESTA(R) treats insomnia in adults. It markets its product to care physicians, allergists, pulmonologists, pediatricians, hospitals, psychiatrists and sleep specialists. It operates in the United States and Canada. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Sepracor Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
